31.03.2022 • NewsSafic-AlcanPeople

Yann Lissillour Appointed CEO of Safic-Alcan

Martial Lecat and Philippe Combette will cease their functions within the Safic-Alcan Executive Committee on Apr. 1, 2022. At the same time, Combette, current Chairman of Safic-Alcan, will hand over the presidency of the group to Yann Lissillour. Lectat and Combette joined Safic-Alcan in June and October 1988 respectively.

Lecat will continue to chair the group's Supervisory Board and Philippe Combette will also remain a member of the Supervisory Board.

The company said that under the leadership of Lecat and Combette, Safic-Alcan has become a European leader in the distribution of specialty raw materials for the formulation industry. It has undergone a profound transformation, which began in the 1990s with a broad diversification of its distribution markets and an internationalization of its activities, both through organic and external growth.

Lissillour joined Safic-Alcan in 2000 and has held various commercial and managerial positions within the group. He has been in charge of acquisitions since 2016 and was appointed COO in November 2021.

Philippe Combette, Yann Lissillour and Martial Lecat, Safic-Alcan. Source:...
Philippe Combette, Yann Lissillour and Martial Lecat, Safic-Alcan. Source: Safic-Alcan

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.